$27.7 Million Project to Advance Gene-Editing Therapies for Rare Immune Diseases
Mayo Clinic joins a $27.7 million ARPA-H project using CRISPR gene editing…
DUPHAT 2026 Concludes with AED 10.3 Billion in Trade Deals
DUPHAT 2026 concludes in Dubai with AED 10.3 billion in trade deals…
M42 Partners with Botswana to Advance Digital Health, Genomics and Precision Medicine
M42 has entered Africa through a 10-year partnership with Botswanaโs Ministry of…
World Health Expo 2027 to Spotlight Growth in Pharma, Biotech and Longevity
World Health Expo 2027 will spotlight pharma, biotech, longevity and wellness from…
Pancreatic Cyst Study Estimates Cancer Risk to Support Early Detection
Mayo Clinic researchers estimate three-year cancer risk in patients with pancreatic cysts,…
$80.5 Million Public Offering to Fund Development of Investigational Cancer Treatment
An $80.5 million public offering will support clinical trials, manufacturing and development…
VANFLYTAยฎ Commercialization Agreement Expands Access to AML Treatment in China
Innovent Biologics and Daiichi Sankyo enter an exclusive agreement to commercialize VANFLYTAยฎ…
Lacutamab Advances Toward Phase 3 Trial in T-Cell Lymphoma
Sobi and Innate Pharma partner to advance lacutamab into a Phase 3…
Healthcare Group Reports AED2.79 Billion Revenue in H1 2026
Burjeel Holdings reported AED2.79 billion in H1 2026 revenue and over 3.7…
FDA Grants Breakthrough Therapy Designation to Olomorasib for Advanced Pancreatic Cancer
The U.S. FDA has granted Breakthrough Therapy designation to Lilly's investigational KRAS…
